FDA-approved for chronic weight management in adults meeting specific criteria
Conflict of interest FG received research support from Eli Lilly, LifeScan, and Takeda and served as a consultant and author for AstraZeneca, Boehringer Ingelheim, Eli Lilly, Merck Sharp and Dohme, Novo Nordisk, Roche Diabetes Care, and Sanofi
James Tang, a kidney specialist and transplant physician at St Vincent's Hospital who did not contribute to the study, said there were a few knowns and some unknowns about how semaglutide helped slow kidney disease progression
doi: 10.1111/apt.16550 40 SyedSBolandBSBourkeLTChenLAChurchillLDobesAet al
SHINEs team takes a medical approach